Annals of Behavioral Medicine

, Volume 42, Issue 3, pp 334–340 | Cite as

Depression and Smoking: Mediating Role of Vagal Tone and Inflammation

  • Laine Taylor
  • Adrian Loerbroks
  • Raphael M. Herr
  • Richard D. Lane
  • Joachim E. Fischer
  • Julian F. Thayer
Original Article

Abstract

Background

Depressed adults are more likely to become nicotine dependent and smokers are at increased risk for depression. Smoking and depression are each associated with inflammation and vagal tone.

Purpose

The purpose of this study is to determine as to what extent the association between depression and smoking is mediated by inflammation and/or vagal tone.

Methods

We studied a cross-sectional occupational sample (n = 647) with information on the number of cigarettes smoked per day and depression (as measured by the Hospital Anxiety and Depression Scale). Heart rate variability, an indicator of vagal tone, was measured by electrocardiographic recordings. Inflammatory markers included C-reactive protein, white blood cells, and fibrinogen. Linear regression was employed along with the Freedman–Schatzkin test to assess mediation.

Results

We observed a positive association between depression and smoking (p < 0.05). Vagal tone and fibrinogen were found to weakly attenuate this association.

Conclusion

These are the first data to demonstrate that the association between depression and smoking may partially be mediated by vagal tone and fibrinogen.

Keywords

Depression Smoking Vagal tone Inflammation Heart rate variability White blood cell count 

References

  1. 1.
    Lasser K, Boyd JW, Woolhandler S, Himmelstein DU, McCormick D, Bor DH. Smoking and mental illness: A population-based prevalence study. JAMA. 2000;284:2606–2610.PubMedCrossRefGoogle Scholar
  2. 2.
    Breslau N, Novak SP, Kessler RC. Psychiatric disorders and stages of smoking. Biol Psychiatry. 2004;55:69–76.PubMedCrossRefGoogle Scholar
  3. 3.
    Tracey KJ. The inflammatory reflex. Nature. 2002;420:853–859.PubMedCrossRefGoogle Scholar
  4. 4.
    Barutcu I, Esen AM, Kaya D, Turkmen M, Karakaya O, Melek M, et al. Cigarette smoking and heart rate variability: Dynamic influence of parasympathetic and sympathetic maneuvers. Ann Noninvasive Electrocardiol. 2005;10:324–329.PubMedCrossRefGoogle Scholar
  5. 5.
    Thayer JF, Sternberg E. Beyond heart rate variability: Vagal regulation of allostatic systems. Ann N Y Acad Sci. 2006;1088:361–372.PubMedCrossRefGoogle Scholar
  6. 6.
    Rottenberg J. Cardiac vagal control in depression: A critical analysis. Biol Psychol. 2007;74:200–211.PubMedCrossRefGoogle Scholar
  7. 7.
    Kemp AH, Quintana DS, Gray MA, Felmingham KL, Brown K, Gatt JM. Impact of depression and antidepressant treatment on heart rate variability: A review and meta-analysis. Biol Psychiatry. 2010;67:1067–1074.PubMedCrossRefGoogle Scholar
  8. 8.
    Ader R, Kelley KW. A global view of twenty years of brain, behavior, and immunity. Brain Behav Immun. 2007;21:20–22.PubMedCrossRefPubMedCentralGoogle Scholar
  9. 9.
    Besedovsky HO, Rey AD. Physiology of psychoneuroimmunology: A personal view. Brain Behav Immun. 2007;21:34–44.PubMedCrossRefGoogle Scholar
  10. 10.
    Irwin MR, Miller AH. Depressive disorders and immunity: 20 years of progress and discovery. Brain Behav Immun. 2007;21:374–383.PubMedCrossRefGoogle Scholar
  11. 11.
    Pike JL, Irwin MR. Dissociation of inflammatory markers and natural killer cell activity in major depressive disorder. Brain Behav Immun. 2006;20:169–174.PubMedCrossRefGoogle Scholar
  12. 12.
    Gorman JM, Sloan RP. Heart rate variability in depressive and anxiety disorders. Am Heart J. 2000;140:77–83.PubMedCrossRefGoogle Scholar
  13. 13.
    Sopori ML, Kozak W. Immunomodulatory effects of cigarette smoke. J Neuroimmunol. 1998;83:148–156.PubMedCrossRefGoogle Scholar
  14. 14.
    Bazzano LA, He J, Muntner P, Vupputuri S, Whelton PK. Relationship between cigarette smoking and novel risk factors for cardiovascular disease in the United States. Ann Intern Med. 2003;138:891–897.PubMedCrossRefGoogle Scholar
  15. 15.
    Frohlich M, Sund M, Lowel H, Imhof A, Hoffmeister A, Koenig W. Independent association of various smoking characteristics with markers of systemic inflammation in men. Results from a representative sample of the general population (MONICA Augsburg Survey 1994/95). Eur Heart J. 2003;24:1365–1372.PubMedCrossRefGoogle Scholar
  16. 16.
    Wannamethee SG, Lowe GD, Shaper AG, Rumley A, Lennon L, Whincup PH. Associations between cigarette smoking, pipe/cigar smoking, and smoking cessation, and haemostatic and inflammatory markers for cardiovascular disease. Eur Heart J. 2005;26:1765–1773.PubMedCrossRefGoogle Scholar
  17. 17.
    Yanbaeva DG, Dentener MA, Creutzberg EC, Wesseling G, Wouters EF. Systemic effects of smoking. Chest. 2007;131:1557–1566.PubMedCrossRefGoogle Scholar
  18. 18.
    Tracey KJ. Physiology and immunology of the cholinergic antiinflammatory pathway. J Clin Invest. 2007;117:289–296.PubMedCrossRefPubMedCentralGoogle Scholar
  19. 19.
    Haensel A, Mills PJ, Nelesen RA, Ziegler MG, Dimsdale JE. The relationship between heart rate variability and inflammatory markers in cardiovascular diseases. Psychoneuroendocrinology. 2008;33:1305–1312.PubMedCrossRefGoogle Scholar
  20. 20.
    Steptoe A, Wardle J, Marmot M. Positive affect and health-related neuroendocrine, cardiovascular, and inflammatory processes. Proc Natl Acad Sci U S A. 2005;102:6508–6512.PubMedCrossRefPubMedCentralGoogle Scholar
  21. 21.
    Carney RM, Freedland KE, Stein PK, Miller GE, Steinmeyer B, Rich MW, et al. Heart rate variability and markers of inflammation and coagulation in depressed patients with coronary heart disease. J Psychosom Res. 2007;62:463–467.PubMedCrossRefPubMedCentralGoogle Scholar
  22. 22.
    Marsland AL, Gianaros PJ, Prather AA, Jennings JR, Neumann SA, Manuck SB. Stimulated production of proinflammatory cytokines covaries inversely with heart rate variability. Psychosom Med. 2007;69:709–716.PubMedCrossRefGoogle Scholar
  23. 23.
    von Kanel R, Thayer JF, Fischer JE. Nighttime vagal cardiac control and plasma fibrinogen levels in a population of working men and women. Ann Noninvasive Electrocardiol. 2009;14:176–184.CrossRefGoogle Scholar
  24. 24.
    Herrmann C, Buss U, Snaith RP. HADS-D—Hospital Anxiety and Depression Scale—Deutsche Version: Ein Fragebogen zur Erfassung von Angst und Depressivität in der somatischen Medizin. Bern: Huber; 1995.Google Scholar
  25. 25.
    Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Heart rate variability. Standards of measurement, physiological interpretation, and clinical use. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Eur Heart J. 1996;17:354–381.Google Scholar
  26. 26.
    Penttila J, Helminen A, Jartti T, Kuusela T, Huikuri HV, Tulppo MP, et al. Time domain, geometrical and frequency domain analysis of cardiac vagal outflow: Effects of various respiratory patterns. Clin Physiol. 2001;21:365–376.PubMedCrossRefGoogle Scholar
  27. 27.
    Clauss A. [Rapid physiological coagulation method in determination of fibrinogen.]. Acta Haematol. 1957;17:237–246.PubMedCrossRefGoogle Scholar
  28. 28.
    Freedman LS, Schatzkin A. Sample size for studying intermediate endpoints within intervention trails or observational studies. Am J Epidemiol. 1992;136:1148–1159.PubMedGoogle Scholar
  29. 29.
    MacKinnon DP, Lockwood CM, Hoffman JM, West SG, Sheets V. A comparison of methods to test mediation and other intervening variable effects. Psychol Methods. 2002;7:83–104.PubMedCrossRefPubMedCentralGoogle Scholar
  30. 30.
    Thayer JF, Fischer JE. Heart rate variability, overnight urinary norepinephrine and C-reactive protein: Evidence for the cholinergic anti-inflammatory pathway in healthy human adults. J Intern Med. 2009;265:439–447.PubMedCrossRefGoogle Scholar
  31. 31.
    Gilpin EA, Pierce JP. The California Tobacco Control Program and potential harm reduction through reduced cigarette consumption in continuing smokers. Nicotine Tob Res. 2002;4 Suppl 2:S157-166.PubMedCrossRefGoogle Scholar
  32. 32.
    Olsson I, Mykletun A, Dahl AA. The Hospital Anxiety and Depression Rating Scale: A cross-sectional study of psychometrics and case finding abilities in general practice. BMC Psychiatry. 2005;5:46.PubMedCrossRefPubMedCentralGoogle Scholar
  33. 33.
    Cole DM, Beckmann CF, Long CJ, Matthews PM, Durcan MJ, Beaver JD. Nicotine replacement in abstinent smokers improves cognitive withdrawal symptoms with modulation of resting brain network dynamics. Neuroimage. 2010;52:590–599.PubMedCrossRefGoogle Scholar
  34. 34.
    Dome P, Lazary J, Kalapos MP, Rihmer Z. Smoking, nicotine and neuropsychiatric disorders. Neurosci Biobehav Rev. 2010;34:295–342.PubMedCrossRefGoogle Scholar
  35. 35.
    McCaffery JM, Papandonatos GD, Stanton C, Lloyd-Richardson EE, Niaura R. Depressive symptoms and cigarette smoking in twins from the National Longitudinal Study of Adolescent Health. Health Psychol. 2008;27:S207-215.PubMedCrossRefGoogle Scholar
  36. 36.
    Li MD, Cheng R, Ma JZ, Swan GE. A meta-analysis of estimated genetic and environmental effects on smoking behavior in male and female adult twins. Addiction. 2003;98:23–31.PubMedCrossRefGoogle Scholar
  37. 37.
    Jorenby DE, Leischow SJ, Nides MA, Rennard SI, Johnston JA, Hughes AR, et al. A controlled trial of sustained-release bupropion, a nicotine patch, or both for smoking cessation. N Engl J Med. 1999;340:685–691.PubMedCrossRefGoogle Scholar
  38. 38.
    Evans DL, Charney DS, Lewis L, Golden RN, Gorman JM, Krishnan KR, et al. Mood disorders in the medically ill: Scientific review and recommendations. Biol Psychiatry. 2005;58:175–189.PubMedCrossRefGoogle Scholar
  39. 39.
    Frasure-Smith N, Lesperance F, Irwin MR, Sauve C, Lesperance J, Theroux P. Depression, C-reactive protein and two-year major adverse cardiac events in men after acute coronary syndromes. Biol Psychiatry. 2007;62:302–308.PubMedCrossRefGoogle Scholar
  40. 40.
    Lanza GA, Sgueglia GA, Cianflone D, Rebuzzi AG, Angeloni G, Sestito A, et al. Relation of heart rate variability to serum levels of C-reactive protein in patients with unstable angina pectoris. Am J Cardiol. 2006;97:1702–1706.PubMedCrossRefGoogle Scholar

Copyright information

© The Society of Behavioral Medicine 2011

Authors and Affiliations

  • Laine Taylor
    • 1
  • Adrian Loerbroks
    • 2
    • 3
    • 4
  • Raphael M. Herr
    • 2
  • Richard D. Lane
    • 1
  • Joachim E. Fischer
    • 2
    • 3
  • Julian F. Thayer
    • 2
    • 5
  1. 1.Department of PsychiatryUniversity of ArizonaTucsonUSA
  2. 2.Mannheim Institute of Public Health, Social and Preventive Medicine, Mannheim Medical FacultyHeidelberg UniversityMannheimGermany
  3. 3.Competence Center for Social Medicine and Occupational Health PromotionHeidelberg UniversityMannheimGermany
  4. 4.Cluster of Excellence “Asia and Europe in a Global Context”Heidelberg UniversityHeidelbergGermany
  5. 5.Department of PsychologyThe Ohio State UniversityColumbusUSA

Personalised recommendations